Source:http://linkedlifedata.com/resource/pubmed/id/10682862
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3
|
pubmed:dateCreated |
2000-3-14
|
pubmed:abstractText |
In order to elucidate molecular events in BCR/ABL-induced transformation, we adopted a polymerase chain reaction (PCR)-based technique of differential display and compared mRNA expression in human factor-dependent cells, TF-1, with that in factor-independent cells, ID-1, which were established from TF-1 cells by transfection of BCR/ABL. Cloning and sequencing of a gene which was upregulated in ID-1 cells revealed that the gene was identical to a melanoma antigen, PRAME. Our present study demonstrated that PRAME was markedly expressed in primary leukemic cells with chronic myeloid leukemia (CML) in blastic crisis and Philadelphia (Ph)+-acute lymphoblastic leukemia (ALL), in which BCR/ABL played an important role as a pathogenic gene. Moreover, comparison of PRAME expression among CD34+ cells with CML in blastic, accelerated, and chronic phases revealed a higher expression in CML in advanced phases. Thus PRAME was considered to be a good candidate for a marker of Ph+-leukemic blast cells as well as a new target antigen of leukemic blast cells that cytotoxic T cells can recognize.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0014-5793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
466
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
367-71
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10682862-Antigens, Neoplasm,
pubmed-meshheading:10682862-Base Sequence,
pubmed-meshheading:10682862-DNA, Complementary,
pubmed-meshheading:10682862-Fusion Proteins, bcr-abl,
pubmed-meshheading:10682862-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:10682862-Humans,
pubmed-meshheading:10682862-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:10682862-Melanoma,
pubmed-meshheading:10682862-Molecular Sequence Data,
pubmed-meshheading:10682862-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:10682862-RNA, Messenger,
pubmed-meshheading:10682862-Tumor Cells, Cultured
|
pubmed:year |
2000
|
pubmed:articleTitle |
Identification of a melanoma antigen, PRAME, as a BCR/ABL-inducible gene.
|
pubmed:affiliation |
Department of Hematology-Oncology, Institute of Medical Science, University of Tokyo, Japan. kiyoshi@ims.u-tokyo.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|